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1. Introduction 
Pyruvate kinase (ATP: pyruvate phosphotransferase, 
EC 2.7.1.40) is known to exist as several isozymes 
[ 11. There is no general agreement about the type of 
enzyme present in erythrocytes. The erythrocyte 
enzyme may be a hybrid between L-type and non-L- 
type subunits [2]. It may be a homotetramer with 
4 identical L-type subunits [3,4]. The homotetramer 
could also be obtained after limited proteolysis of an 
enzyme composed of 2 Ltype subunits and 2 subunits 
with a somewhat greater molecular weight [4]. 
L-type pyruvate kinase is the main isozyme in liver. 
It is also present in the kidney and intestine [5,6]. 
The regulation of its activity is under hormonal control 
[7]. Potent effecters of the activity of pyruvate kinase 
type L are fructose-l ,6-diphosphate, ATP and alanine 
[8]. The L-type isozyme has been shown to be phos- 
phorylated under the influence of cyclic AMP-depend- 
ent protein kinase in vitro [9]. This phosphorylation 
has also been observed in liver slices [lo]. Phosphoryl- 
ated pyruvate kinase has a lower affinity for phospho- 
enolpyruvate than the unphosphorylated enzyme 
[9,1 I]. An even more inhibited form of pyruvate 
kinase is obtained by proteolytic removal of a phos- 
phorylated peptide with very low concentrations of 
subtilisin [ 121. 
The present work demonstrates that partially 
purified erythrocyte pyruvate kinase from the rat, 
in contrast to liver pyruvate kinase, is not phospho- 
rylated in vitro in the presence of cyclic AMP-depend- 
ent protein kinase and ATP. The enzyme binds, how- 
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ever, to anti-L-type pyruvate kinase-IgG-Sepharose. 
The kinetic properties of the rat erythrocyte pyruvate 
kinase strongly resemble those of subtilisin-modified 
L-type enzyme. The results indicate that erythrocyte 
pyruvate kinase is a proteolytically modified L-type 
enzyme. 
2. Material and methods 
Bovine serum albumin, fructose-l ,6-diphosphate, 
dithiothreitol, NADH, phosphoenolpyruvate (PEP), 
ADP and ATP were purchased from Sigma. Rabbit 
lactate dehydrogenase was a product of Boehringer- 
Mannheim. DEAE-Sephadex A-50 was obtained 
from Pharmacia, Uppsala. [32P]ATP was bought from 
New England Nuclear, Boston. 
Protein determination was based on the A!!__ = 
10-oA280 nm. 
The catalytic subunit of cyclic AMP-stimulated 
protein kinase from rat liver was isolated as in [ 131. 
Pyruvate kinase from rat liver was prepared as in 
[ 141. Blood for preparation of erythrocyte pyruvate 
kinase was obtained by decapitation of anesthetized 
adult rats. The blood was collected in 0.9% NaCl con- 
taining 10 mM EDTA, and was left for 2 h to cool and 
sediment at 4°C. All subsequent steps were performed 
at 4°C. The blood cells were centrifuged at 3000 X g 
for 10 min, then washed 3 times with 0.9% NaCl. The 
erythrocytes were hemolysed in 2 vol. 0.5 mM dithio- 
threitol containing 0.5 mM EDTA under stirring for 
at least 2 h or overnight. The hemolysate was centri- 
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fuged at 17 500 X g for 45 min. The pellet was dis- 
carded. The supernatant was diluted with 2 vol. 30% 
(v/v) glycerol containing 0.1 mM dithiothreitol. An 
equal volume of DEAE-Sephadex A-50 equilibrated 
with 10 mM potassium phosphate, pH 7.0, was added 
to the diluted hemolysate and stirred for 30 min. The 
gel with absorbed protein was washed on a Btichner 
funnel with lo-20 vol. 10 mM potassium phosphate 
(pH 7.0), 30% (v/v) glycerol and 0.1 mM dithiothreitol 
until Azse = 0.1 and then packed on a column. The 
DEAE-Sephadex column was eluted at pH 7.0 with 
a linear gradient from 100 mM potassium phosphate, 
pH 7.0, to 500 mM potassium phosphate containing 
30% glycerol and 0.1 mM dithiothreitol. The total 
gradient consisted of 5 column vol. Fractions from 
the DEAE-Sephadex chromatography were analyzed 
for pyruvate kinase activity. The material that con- 
tained pyruvate kinase was pooled and concentrated 
to about 10 units pyruvate kinase/ml and stored at 
-18°C. For calculations, the specific activities of 
290 units/mg [3] and 450 units/mg [ 141 were used 
for the erythrocyte and rat liver enzymes,respectively. 
L-Type pyruvate kinase that had been digested with 
low concentrations of subtilisin was obtained [ 121. 
Pyruvate kinase from erythrocytes and from liver 
were phosphorylated at 1 mM [32P]ATP (spec. act. 
- 30 cpm/pmol). The incubation medium had vol. 
0.5 ml and contained 0.6 units pyruvate kinase, 
22 mM potassium phosphate (pH 7.0) 6% (v/v) glyc- 
erol, 0.02 mM dithiothreitol and 10 mM magnesium 
acetate. The catalytic subunit from rat liver protein 
kinase was added in excess (3-4-times) of the 
amount of pyruvate kinase. The reaction was run for 
30 min at 30°C and was terminated by the addition 
of 2 ml ice-cold 10% (w/v) trichloroacetic acid con- 
taining 50 mM H3P04. The precipitates were spun 
down. The pellets were dissolved in 0.2 ml 0.5 M 
NaOH and reprecipitated with 2 ml 10% trichloro- 
acetic acid containing 50 mM H3P04. This was 
repeated 3 times. After the last centrifugation the 
pellets were dissolved in 0.5 ml 0.5 M NaOH and the 
radioactivity was measured as Cerenkov radiation [ 151. 
Pyruvate kinase activity was measured according 
to a modification [6] of the methods in [ 161 during 
the purification and phosphorylation of the enzymes. 
The kinetic experiments were performed as in [ 111. 
For each determination 0.03 unit of enzyme was used. 
Protein kinase was assayed as in [ 141. One unit of 
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catalytic subunit from the protein kinase was defined 
as the activity that transfers 1 pmol phosphate from 
ATP into histone/min [ 141. 
An immunoadsorbent column of Sepharose 6B, 
coupled with antibodies against L-type pyruvate 
kinase from the rat, was obtained [lo]. The gel was 
equilibrated with 20 mM potassium phosphate buffer, 
pH 7 .O, containing 0.9% NaCl. After the pyruvate 
kinase had become attached to the immunoadsorbent 
column the column was washed with the buffer con- 
taining 9% NaCl. 
3. Results and discussion 
Pyruvate kinase from erythrocytes and liver pyruvate 
kinase adhered to anti-L-type pyruvate kinase-IgG- 
Sepharose. Two columns, each containing 1 ml immuno- 
adsorbent, were packed. About lo-30 pg pyruvate 
kinase from erythrocytes and liver, respectively, were 
applied to the 2 separate columns. About 80-100% 
of both enzyme forms adhered to the immunoadsor- 
bent. On immunodiffusion in agar gels as in [ 171, the 
erythrocyte pyruvate kinase and the subtilisin-treated 
L-type pyruvate kinase appeared identical to L-type 
pyruvate kinase. The concentration of erythrocyte 
pyruvate kinase was very low in the experiment. This 
strongly indicates that the L-type and the erythrocyte 
pyruvate kinases are immunologically related, as has 
been shown by other investigators on the human 
enzymes [3,4]. 
If the erythrocyte pyruvate kinase is identical to 
the liver and kidney L-type isozyme it would be 
expected to be a substrate of cyclic AMP-dependent 
protein kinase. In order to test this hypothesis the 
enzyme was incubated with Mg2’- [32P]ATP plus the 
catalytic subunit from cyclic AMP-stimulated protein 
kinase from rat liver. No or low incorporation of 32P 
into the erythrocyte pyruvate kinase was observed 
when the enzyme was incubated either alone or mixed 
with liver pyruvate kinase (table 1). When the enzymes 
were mixed only the liver pyruvate kinase was phos- 
phorylated. The results suggest hat the catalytic 
subunit of protein kinase was active and that no 
inhibitor of this enzyme was present in the prepara- 
tion of the erythrocyte pyruvate kinase. To ascertain 
that erythrocyte pyruvate kinase was not a phospho- 
rylated form of pyruvate kinase, it was incubated with 
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Table 1 
Incorporation of ‘*P into pyruvate kinase isozymes when incubated with 
Mg*+-[“P]ATP and catalytic subunit of cyclic AMP-dependent 
protein kinase 
Sample Enzyme ‘*P Incorporated 
subunit (pmol) into enzyme (pmol) 
Liver pyruvate kinase 100 94 
Erythrocyte pyruvate kinase 160 0 
Liver pyruvate kinase + 50 56 
Erythrocyte pyruvate kinase 80 
Conditions as in section 2. The results of a representative xperiment are given 
phosphatase, which had no effect on the enzyme (data 
not given). 
In order to further compare the liver and erythro- 
cyte pyruvate kinase, some kinetic experiments were 
run. The activity of pyruvate kinase from rat liver and 
rat erythrocytes as a function of the concentration of 
PEP is presented in fig.1. The erythrocyte isozyme 
showed a lower affinity for PEP than the liver isozyme. 
The Ko.5 for PEP of the erythrocyte pyruvate kinase 
was 1.8 mM. For the liver enzyme Ko5 for PEP was 
0.4 mM. L-Type pyruvate kinase treated with low 
concentrations of subtilisin [ 121 loses its ability to be 
phosphorylated and exhibits a reduced affinity for 
10 20 30 LO 50 
PHOSPHOENOLPYRUVATE I mM I 
Fig.1. Enzyme activity of liver and erythrocyte pyruvate kinase 
at pH 7.3 and 30°C as a function of the concentration of 
phosphoenolpyruvate. No fructose-1,6diphosphate or ATP 
was added. The assay conditions were as in section 2. 
(o-o) Liver pyruvate kinase. (e-0) Erythrocyte pyruvate 
kinase. (a’*) Liver pyruvate kinase treated with low con- 
centrations of subtilisin. 
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PEP. The subtilisin-treated pyruvate kinase from liver 
has a Ko5 for PEP of 1.8 mM, which is similar to the 
Ko, for PEP of the erythrocyte pyruvate kinase (fig. 1). 
The dependence of the two pyruvate kinases on 
pH is illustrated in lig.2. The concentration of PEP in 
these experiments was 0.2 mM. The enzyme activity 
of the erythrocyte enzyme was nearly the same for all 
pHvalues tested, while the activity of the liver enzyme 
increased at lower pH values. A pH curve similar to 
that of the erythrocyte pyruvate kinase was also 
obtained with the L-type pyruvate kinase after treat- 
ment with low concentrations of subtilisin [ 121. 
In fig.3 the effect of fructose-l ,6-diphosphate in 
1 
60 
J 
70 8.0 
pH at 3ooc 
Fig.2. pHdependence at 30°C of liver pyruvate kinase and 
the erythrocyte isozyme tested at 0.2 mM phosphoenol- 
pyruvate and 2 mM ADP. (o-o) Liver pyruvate kinase. 
(e-e) Erythrocyte pyruvate kinase. (.-*) Liver pyruvate 
kinase treated with low concentrations of subtilisin. 
141 
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10 20 30 LO 
FRUCTOSE - 1.6 -DIPhOSPHATE l)lMl 
Fig.3. The activity of L-type pyruvate kinase and erythrocyte 
pyruvate kinase at pH 7.3 and 30°C as a function of fructose- 
1,6diphosphate in the presence and absence of 2 mM ATP. 
Phosphoenolpyruvate cont. 0.2 mM. Open symbols and 
closed symbols represent the activity in the presence and 
absence of 2 mM ATP, respectively. (o-o, o-o) Liver 
pyruvate kinase. (A--A, A-A) Erythrocyte pyruvate 
kinase. (0-0, e-m) Liver pyruvate kinase treated with 
low concentrations of subtilisin. 
the presence and absence of 2 mM ATP is shown for 
the 3 pyruvate kinases. Ko,5 for the erythrocyte 
enzyme and the liver enzyme were 0.4 PM and 0.1 PM 
fructose-l ,6-diphosphate, respectively, in the absence 
of ATP and 0.9 PM and 0.2 PM in the presence of 
ATP. The ATP inhibition could not be overcome by 
high concentrations of fructose-l ,6-diphosphate with 
any of the enzyme forms. The dependence of the 
erythrocyte pyruvate kinase on fructose-l ,6-diphos- 
phate in the presence and absence of 2 mM ATP was 
very similar to the dependence on these effecters of 
the L-type pyruvate kinase modified with low con- 
centrations of subtilisin [ 121. The profile of the 
curves appears to be the same. Furthermose, the 
same Ko5 values for fructose-l ,6-diphosphate were 
obtained. 
Pyruvate kinase from the liver and that from 
erythrocytes seem to be immunologically related or 
identical, as shown here and [3]. In spite of this 
observation the erythrocyte pyruvate kinase cannot 
be phosphorylated in the presence of catalytic subunit 
from cyclic AMP-stimulated protein kinase from rat 
liver in our system. In vitro the existence of one form 
of L-type pyruvate kinase that has lost its ability to 
be phosphorylated is known. This is an enzyme that 
has been digested with very low concentrations of 
subtilisin [ 121. The removal of the phosphorylatable 
peptide changed the affinity of the enzyme for the 
substrate PEP without affecting its V,, [ 121. 
The erythrocyte pyruvate kinase might be an 
L-type pyruvate kinase that has been modified by 
proteolysis in the cell. The kinetic and pH dependence 
studies in this report strongly support this idea. In all 
kinetic experiments the properties of the erythrocyte 
isozyme were very similar to those of liver pyruvate 
kinase modified by subtilisin. This should then be the 
first report of the existence of such a modified enzyme 
in the cell. Concerning human erythrocyte pyruvate 
kinase proteolytic modification with trypsin in vitro 
was reported [4]. 
The fact that the proteolytic activity of a hemolysate 
towards phosphorylated pyruvate kinase is much 
greater than that of a cell sap from rat liver provides 
good support for this theory (P. Ekman and U. D. E., 
to be published). 
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